<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<meta name="Generator" content="Microsoft Word 14 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
        {font-family:Wingdings;
        panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
        {font-family:Wingdings;
        panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:Tahoma;
        panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0cm;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";
        mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
        {mso-style-priority:99;
        mso-style-link:"Balloon Text Char";
        margin:0cm;
        margin-bottom:.0001pt;
        font-size:8.0pt;
        font-family:"Tahoma","sans-serif";
        mso-fareast-language:EN-US;}
span.EmailStyle17
        {mso-style-type:personal-compose;
        font-family:"Tahoma","sans-serif";
        color:windowtext;}
span.BalloonTextChar
        {mso-style-name:"Balloon Text Char";
        mso-style-priority:99;
        mso-style-link:"Balloon Text";
        font-family:"Tahoma","sans-serif";}
span.jbtcls762057content-bold
        {mso-style-name:jbtcls_76_2057_content-bold;}
span.apple-converted-space
        {mso-style-name:apple-converted-space;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-family:"Calibri","sans-serif";
        mso-fareast-language:EN-US;}
@page WordSection1
        {size:612.0pt 792.0pt;
        margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
        {page:WordSection1;}
/* List Definitions */
@list l0
        {mso-list-id:848176240;
        mso-list-template-ids:1308762778;}
@list l0:level1
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:36.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l0:level2
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:72.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l0:level3
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:108.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l0:level4
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:144.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l0:level5
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:180.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l0:level6
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:216.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l0:level7
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:252.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l0:level8
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:288.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l0:level9
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:324.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l1
        {mso-list-id:2042120543;
        mso-list-template-ids:-298128330;}
@list l1:level1
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:36.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l1:level2
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:72.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l1:level3
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:108.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l1:level4
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:144.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l1:level5
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:180.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l1:level6
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:216.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l1:level7
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:252.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l1:level8
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:288.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
@list l1:level9
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:324.0pt;
        mso-level-number-position:left;
        text-indent:-18.0pt;
        mso-ansi-font-size:10.0pt;
        font-family:Wingdings;}
ol
        {margin-bottom:0cm;}
ul
        {margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-GB" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;">Galapagos is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of
 action.&nbsp;<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;">Our pipeline comprises Phase 2, Phase 1, pre-clinical and discovery studies in cystic fibrosis, inflammation, fibrosis, osteoarthritis and other
 indications.<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;">We have discovered and developed filgotinib: in collaboration with Gilead we aim to bring this JAK1-selective inhibitor for inflammatory indications
 to patients all over the world.<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;">Galapagos is focused on the development and commercialization of novel medicines that will improve people&#8217;s lives.<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;">The Galapagos group, including fee-for-service subsidiary Fidelta, has approximately 435 employees, operating from its Mechelen, Belgium headquarters
 and facilities in The Netherlands, France, and Croatia. More information at <a href="http://www.glpg.com">
<span style="color:windowtext">www.glpg.com</span></a>.<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;color:#5D5D5D"><o:p>&nbsp;</o:p></span></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;color:#5D5D5D">For our site in Mechelen, we are looking for a<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:18.0pt"><b><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;color:#E46C0A;mso-style-textfill-fill-color:#E46C0A;mso-style-textfill-fill-alpha:100.0%;mso-fareast-language:EN-GB">Scientist Bioinformatics
 (MEC-217)<o:p></o:p></span></b></p>
<p class="MsoNormal" style="line-height:18.0pt"><b><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;color:#E46C0A;mso-style-textfill-fill-color:#E46C0A;mso-style-textfill-fill-alpha:100.0%;mso-fareast-language:EN-GB">&gt; Also see:
<a href="http://www.glpg.com/docs/view/5831de2c52d44-en"><span style="color:#0000BF;mso-style-textfill-fill-color:#0000BF;mso-style-textfill-fill-alpha:100.0%">http://www.glpg.com/docs/view/5831de2c52d44-en</span></a><o:p></o:p></span></b></p>
<p class="MsoNormal" style="line-height:18.0pt"><b><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;color:#E46C0A;mso-style-textfill-fill-color:#E46C0A;mso-style-textfill-fill-alpha:100.0%;mso-fareast-language:EN-GB"><o:p>&nbsp;</o:p></span></b></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;">Do you have the qualifications for this job opening, and are you up to the challenge of joining our entrepreneurial team?<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;">If so, please send your application (preferably by e-mail) to:<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;">Human Resources<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;"><a href="mailto:jobs_be@glpg.com">jobs_be@glpg.com</a><o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;">Galapagos NV - Human Resources<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;">Generaal De Wittelaan L11 A3<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;">B-2800 Mechelen, Belgium</span><b><span style="font-size:9.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;color:#E46C0A;mso-style-textfill-fill-color:#E46C0A;mso-style-textfill-fill-alpha:100.0%;mso-fareast-language:EN-GB"><o:p></o:p></span></b></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;color:#5D5D5D;mso-fareast-language:EN-GB"><o:p>&nbsp;</o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;color:#5D5D5D;mso-fareast-language:EN-GB">Function description<o:p></o:p></span></b></p>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;mso-fareast-language:EN-GB">As a member of the bioinformatics team you will participate in bioinformatics efforts supporting the drug discovery projects
 at Galapagos.<br>
By carrying out functional analyses, data integration, and implementing and executing data analysis methodologies, you work with the multidisciplinary disease biology and drug discovery teams in acquiring scientific insights to direct the research strategy.<br>
You will play a key role in implementing bioinformatics tools and methods supporting a wide range of activities, from research projects to proof-of-concept studies. In collaboration with the Information Systems (IS) team, these tools will be incorporated into
 Galapagos&#8217; informatics infrastructure.<br>
This position offers an exciting opportunity to develop and deploy bioinformatics-driven solutions to the scientific community at Galapagos.<br>
<span style="color:#5D5D5D"><br>
<b>Required skills and experience:</b><o:p></o:p></span></span></p>
<ul type="square">
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:18.0pt;mso-list:l0 level1 lfo1">
<span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;mso-fareast-language:EN-GB">Degree (MSc with at least 3 years of relevant work experience or PhD) in a biological or chemical discipline with a demonstrated track record in bioinformatics, preferably
 in a pharma/biotech setting<o:p></o:p></span></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:18.0pt;mso-list:l0 level1 lfo1">
<span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;mso-fareast-language:EN-GB">roadly applicable general bioinformatics skills (pathway analysis, data and text mining, querying databases and repositories in the public domain)<o:p></o:p></span></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:18.0pt;mso-list:l0 level1 lfo1">
<span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;mso-fareast-language:EN-GB">Knowledge of expression data analysis (micro-arrays and/or sequencing-based) and experience in developing analysis strategies and workflows in transcriptomics<o:p></o:p></span></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:18.0pt;mso-list:l0 level1 lfo1">
<span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;mso-fareast-language:EN-GB">Working knowledge of Linux and programming expertise (e.g., C#, Java, Perl or Python)<o:p></o:p></span></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:18.0pt;mso-list:l0 level1 lfo1">
<span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;mso-fareast-language:EN-GB">Strong problem-solving ability, and the aptitude and zeal to acquire new skills necessary for the job<o:p></o:p></span></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:18.0pt;mso-list:l0 level1 lfo1">
<span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;mso-fareast-language:EN-GB">Rigorous and well organized; good verbal and written English communication skills<o:p></o:p></span></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:18.0pt;mso-list:l0 level1 lfo1">
<span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;mso-fareast-language:EN-GB">Team player able to work and communicate effectively in a multidisciplinary environment with people with different professional backgrounds (biology, chemistry, molecular
 modelling, IS, IT)<o:p></o:p></span></li></ul>
<p class="MsoNormal" style="line-height:18.0pt"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;color:#5D5D5D;mso-fareast-language:EN-GB">&nbsp;<b>Desirable skills:</b><o:p></o:p></span></p>
<ul type="square">
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:18.0pt;mso-list:l1 level1 lfo2">
<span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;mso-fareast-language:EN-GB">Good knowledge of R (and the BioConductor libraries) and experience with reporting in R (sweave/knitr) and interactive web-interfaces (R/shiny)<o:p></o:p></span></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:18.0pt;mso-list:l1 level1 lfo2">
<span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;mso-fareast-language:EN-GB">Knowledge of disease-related pathways and systems biology approaches in relation to drug target discovery<o:p></o:p></span></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:18.0pt;mso-list:l1 level1 lfo2">
<span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;mso-fareast-language:EN-GB">Good understanding of statistics and experimental design<o:p></o:p></span></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:18.0pt;mso-list:l1 level1 lfo2">
<span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;;mso-fareast-language:EN-GB">Understanding of data structures and data-interchange formats (e.g. JSON) and experience with document databases (such as MongoDB or Cassandra) and/or relational databases
 (MySQL/Oracle)<o:p></o:p></span></li></ul>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;"><o:p>&nbsp;</o:p></span></p>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse">
<tbody>
<tr>
<td width="80" valign="top" style="width:60.3pt;border:none;border-right:dotted #004D43 1.0pt;padding:0cm 5.4pt 0cm 5.4pt">
<p class="MsoNormal"><a href="http://www.glpg.com/"><span style="font-size:8.0pt;color:black;mso-fareast-language:EN-GB;text-decoration:none"><img border="0" width="65" height="40" id="Picture_x0020_2" src="cid:image001.jpg@01D2444C.16287880" alt="cid:image001.jpg@01D16D66.BD487830"></span></a><span style="font-size:8.0pt;color:black;mso-fareast-language:NL-BE"><o:p></o:p></span></p>
</td>
<td width="250" valign="top" style="width:187.8pt;border:none;border-right:dotted #004D43 1.0pt;padding:0cm 5.4pt 0cm 5.4pt">
<p class="MsoNormal"><b><span lang="EN-US" style="font-size:10.0pt;color:#004D43;mso-fareast-language:NL-BE">Maté Ongenaert,
<i>PhD</i></span></b><b><span lang="EN-US" style="font-size:10.0pt;color:black;mso-fareast-language:NL-BE"><br>
</span></b><span lang="EN-US" style="font-size:8.0pt;color:#595959;mso-fareast-language:NL-BE">Senior Scientist Bioinformatics&nbsp;
<br>
T: &#43;32 15 342 927</span><span lang="EN-US" style="font-size:8.0pt;color:black;mso-fareast-language:NL-BE"><o:p></o:p></span></p>
</td>
<td width="170" valign="top" style="width:127.15pt;padding:0cm 5.4pt 0cm 5.4pt">
<p class="MsoNormal"><b><span lang="NL-BE" style="font-size:10.0pt;color:#004D43;mso-fareast-language:NL-BE">Galapagos NV<br>
</span></b><span lang="NL-BE" style="font-size:8.0pt;color:#595959;mso-fareast-language:NL-BE">Generaal De Wittelaan L11 A3<br>
2800 Mechelen</span><span lang="NL-BE" style="font-size:8.0pt;color:#7F7F7F;mso-fareast-language:NL-BE">
</span><span lang="NL-BE" style="font-size:8.0pt;color:#D0CECE;mso-fareast-language:NL-BE">&#8226;</span><span lang="NL-BE" style="font-size:8.0pt;color:#7F7F7F;mso-fareast-language:NL-BE">
</span><span lang="NL-BE" style="font-size:8.0pt;color:#595959;mso-fareast-language:NL-BE">Belgium</span><span lang="NL-BE" style="font-size:8.0pt;color:black;mso-fareast-language:NL-BE"><o:p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal"><span lang="NL-BE" style="mso-fareast-language:EN-GB"><o:p>&nbsp;</o:p></span></p>
<p class="MsoNormal"><span lang="NL-BE" style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;"><o:p>&nbsp;</o:p></span></p>
<p class="MsoNormal"><span lang="NL-BE" style="font-size:10.0pt;font-family:&quot;Tahoma&quot;,&quot;sans-serif&quot;"><o:p>&nbsp;</o:p></span></p>
</div>

<br><HR><BR>This e-mail and its attachment(s) (if any) may contain confidential and/or proprietary information and is intended for its addressee(s) only. Any unauthorized use of the information contained herein (including, but not limited to, alteration, reproduction, communication, distribution or any other form of dissemination) is strictly prohibited. If you are not the intended addressee, please notify the originator promptly and delete this e-mail and its attachment(s) (if any) subsequently. 

Neither Galapagos nor any of its affiliates shall be liable for direct, special, indirect or consequential damages arising from alteration of the contents of this message (by a third party) or as a result of a virus being passed on.


<br></body>
</html>